Abstract: The present invention relates to fusion proteins comprising anti-Oomycotic proteins or peptides linked to an antibody or fragment thereof specifically recognising an epitope of an Oomycota. The invention is also directed to polynucleotides coding for the fusion proteins. The embodiments of the present invention are particularly useful for the protection of plants against Oomycota. The invention therefore comprises transgenic plants expressing the fusion proteins of the present invention.
Type:
Application
Filed:
August 5, 2010
Publication date:
February 16, 2012
Applicant:
Fraunhofer-Gesellschaft zur Forderung der angewandten e.V.
Inventors:
Sylvia Schleker, Dieter Peschen, Rainer Fischer, Stefan Schillberg
Abstract: The present invention relates to an arrangement having at least one solar cell, which is formed by a first sequence of differently doped layers (1, 2, 11, 12) on a substrate (6, 16), and at least one bypass diode, which is connected to the solar cell, particularly in a monolithic, series-connected solar module. The arrangement is characterized in that the bypass diode is formed by a second sequence of layers (4, 5, 13, 14), which is arranged between the substrate (6, 16) and the first layer sequence (1, 2, 11, 12). With the proposed arrangement monolithic, series-connected solar modules can be formed at a very low loss of active receiving surface, the solar cells of which are protected by bypass diodes.
Type:
Grant
Filed:
November 3, 2005
Date of Patent:
April 26, 2011
Assignees:
Fraunhofer-Gesellschaft zur Förderung der angewandten e.V., Albert-Ludwigs-Universtät, AZUR SPACE Solar Power GmbH
Inventors:
Sascha Van Riesen, Rüdiger Löckenhoff, Gerhard Strobl, Ron Dietrich, Wolfgang Koestler
Abstract: In a method for assessing the quality of an audio test signal derived from an audio reference signal by coding and decoding, the audio test signal is compared with the audio reference signal, as it were, behind the cochlea of the human ear. All masking effects as well as the transmission function of the ear are equally applied to the audio reference signal and the audio test signal. To this end, the audio test signal is broken down according to its spectral composition by means of a first bank of filters consisting of filters overlapping in frequency and defining spectral regions, said filters having differing filtering functions each determined on the basis of the excitation curve of the human ear with respect to the respective filter center frequency. The audio reference signal is also broken down according to its spectral composition into partial audio reference signals by means of a second bank of filters coinciding with the first bank of filters.
Type:
Grant
Filed:
May 12, 1999
Date of Patent:
August 7, 2001
Assignee:
Fraunhofer-Gesellschaft zur Förderung der Angewandten
e.V.